Abstracts Archive - Page 1621 of 2425 - ACR Meeting Abstracts

Abstract Number: 3060 • 2016 ACR/ARHP Annual Meeting
Development and Implementation of a Question-Based Tool Promoting Learning of Relevant Epidemiology and Biostatistics in Rheumatology: The Critical Literature Assessment Skills Support – Rheumatology (CLASS-Rheum) Pilot
Juliet Aizer¹, Julie Schell², Christopher Collins³, Lisa Criscione-Schrieber⁴, Pascale Schwab⁵, Karina Marianne D. Torralba⁶, Anne R. Bass¹, Jessica Berman¹, Alexa Adams¹, Stephen A. Paget¹, Rima Abhyankar⁷, Kelly McHugh⁷ and Lisa Mandl¹, ¹Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ²University of Texas, Austin, TX, ³Medicine, MedStar Washington Hospital Center/ Georgetown University Medical Center, Washington, DC, ⁴Rheumatology, Duke University Medical Center, Durham, NC, ⁵Rheumatology, Oregon Health and Science University, Portland, OR, ⁶Division of Rheumatology, Department of Internal Medicine, Loma Linda University, Loma Linda, CA, ⁷Hospital for Special Surgery, New York, NY
Background/Purpose: Understanding epidemiology and biostatistics is crucial for rheumatologists to accurately interpret the rheumatic disease literature and make appropriate clinical decisions. In 2014 rheumatology program…
Abstract Number: 3061 • 2016 ACR/ARHP Annual Meeting
Future Challenges in Pediatric Rheumatology: The Role of Graduate Medical Education (GME)
Lisa Imundo¹, Marcy B. Bolster², Seetha Monrad³, Daniel Battafarano⁴, Marisa Klein-Gitelman⁵, Jonathan S. Hausmann⁶ and Marcia Ditmyer⁷, ¹Pediatrics, Columbia University, New York, NY, ²Massachusetts General Hospital, Boston, MA, ³Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ⁴Medicine, San Antonio Military Medical Center, San Antonio, TX, ⁵Pediatrics, Northwestern University, Chicago, IL, ⁶Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ⁷Academy for Academic Research, Las Vegas, NV
Background/Purpose: The 2015 ACR/AHRP Workforce Study examined the adequacy of the future supply of and demand for rheumatology services in the U.S. Understanding the role…
Abstract Number: 3062 • 2016 ACR/ARHP Annual Meeting
Use of Script Concordance Testing to Evaluate the Efficacy of a Web-Based Module on Gout: Three Years of Experience
Bernadette C. Siaton¹, Elizabeth Clayton², Alexandra M. Kueider³ and Matthew Rietschel⁴, ¹Rheumatology, University of Maryland School of Medicine, Baltimore, MD, ²Edmund J. MacLaughlin, M.D., L.L.C., Easton, MD, ³Laboratory of Behavioral Neuroscience -Unit of Clinical and Translational Neuroscience, National Institute on Aging, Baltimore, MD, ⁴University of Maryland School of Nursing, Baltimore, MD
Background/Purpose: Despite the prevalence of musculoskeletal conditions, the majority of internal medicine trainees at the University of Maryland complete residency with little exposure to rheumatology…
Abstract Number: 3063 • 2016 ACR/ARHP Annual Meeting
Learning Rheumatology through Fellow-Generated Questions: The Rheumatology Image of the Week Project
Jonathan S. Hausmann, Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA; Rheumatology, Boston Children's Hospital, Boston, MA
Background/Purpose: There has been increasing interest in using online tools to train physicians. However, most online content does not encourage active learning, and as a…
Abstract Number: 3064 • 2016 ACR/ARHP Annual Meeting
From Art to Science: A Mobile App for Point-of-Care Relevance Determination for the Musculoskeletal Exam
Joy-Ann Tabanor, Joongheum Park, Heidi-Anne Hanson and Hnin Hnin Oo, Department of Medicine, Englewood Hospital and Medical Center, Englewood, NJ
Background/Purpose: The physical exam is an essential part of the assessment of patients with musculoskeletal (MSK) complaints. Few doctors are aware of the sensitivity and specificity…
Abstract Number: 3065 • 2016 ACR/ARHP Annual Meeting
Mortality in Patients with Rheumatoid Arthritis and Interstitial Lung Disease Treated with First Line TNFi or Rituximab Therapies
Katie Druce¹, Kundan Iqbal², Kath Watson¹, Deborah P.M. Symmons¹, Kimme L. Hyrich¹ and Clive Kelly³, ¹Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ²Newcastle University, Newcastle, United Kingdom, ³Rheumatology, Queen Elizabeth Hospital, Gateshead, United Kingdom
Mortality in Patients With Rheumatoid Arthritis and Interstitial Lung Disease Treated With First Line TNFi or Rituximab Therapies Druce KL, Iqbal K, Watson K, Symmons…
Abstract Number: 3066 • 2016 ACR/ARHP Annual Meeting
Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
Bryant R. England¹, Sofia Pedro², Ted R Mikuls³ and Kaleb Michaud^2,4, ¹Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²National Data Bank for Rheumatic Diseases, Wichita, KS, ³Veteran Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, ⁴Rheumatology, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: The immune system recognizes, controls, and eliminates tumors through a process of immunosurveillance. In RA, where there is an increased incidence of lymphoma and…
Abstract Number: 3067 • 2016 ACR/ARHP Annual Meeting
Treatment Decisions Following Diagnosis of Cancer during TNFi Inhibitor Treatment in Patients with Rheumatoid Arthritis: Results from the BSRBR-RA
Katie Druce¹, Diederik Decock², Kath Watson¹, Deborah P.M. Symmons¹ and Kimme L. Hyrich¹, ¹Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, ²KU Leuven Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, Leuven, Belgium
Treatment Decisions Following Diagnosis of Cancer During TNFi inhibitor Treatment in Patients with Rheumatoid Arthritis: results from the BSRBR-RA Druce KL, De Cock D, Watson…
Abstract Number: 3068 • 2016 ACR/ARHP Annual Meeting
Smoking and Excess Weight Attenuate Rate of Improvement over First 3 Years in Early RA
Susan J. Bartlett^1,2, Orit Schieir³, Kathleen Andersen⁴, Gilles Boire⁵, Boulos Haraoui⁶, Carol Hitchon⁷, Edward Keystone⁸, Janet E. Pope⁹, J Carter Thorne¹⁰, Diane Tin¹¹, Vivian P. Bykerk¹² and Canadian Early Arthritis Cohort (CATCH) Investigators, ¹Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ²Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Hospital for Special Surgery, New York, NY, ⁵Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, ⁶1551, Ontario Street East, Institut de Recherche en Rhumatologie de Montréal (IRRM), Montreal, QC, Canada, ⁷University of Manitoba, Winnipeg, MB, Canada, ⁸Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁹University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ¹⁰Southlake Regional Health Centre, Newmarket, ON, Canada, ¹¹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹²Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Early, aggressive treatment to achieve remission is the primary goal when treating early RA, and is associated with improved long-term outcomes. We have previously…
Abstract Number: 3069 • 2016 ACR/ARHP Annual Meeting
Weight Loss in the Early Rheumatoid Arthritis Period Is Associated with Subsequent Increased Mortality in RA Patients and Matched Comparators: Evidence Against an RA-Specific Obesity Paradox
Jeffrey A. Sparks¹, Shun-Chiao Chang², Uyen Sa D.T. Nguyen^3,4, Medha Barbhaiya², Sara K. Tedeschi², Bing Lu², Karen H. Costenbader², Yuqing Zhang⁵, Hyon K. Choi⁶ and Elizabeth W. Karlson², ¹Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ³Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ⁴Boston University School of Medicine, Boston, MA, ⁵Clinical Epidemiology and Training Unit, Boston University School of Medicine, Boston, MA, ⁶Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Background/Purpose : Weight loss may explain the obesity paradox for mortality, since those who unintentionally lose weight to reach normal BMI may have higher mortality…
Abstract Number: 3070 • 2016 ACR/ARHP Annual Meeting
Effect of Sarcopenia, Subcutaneous Adipose Tissue and Abdominal Visceral Fat on Mortality Risk of Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study
Felipe M Santana¹, Michel A Gonçalves², Diogo S Domiciano³, Luana G Machado³, Jaqueline B Lopes³, Camille P Figueiredo³, Valéria Caparbo³, Liliam Takayama³ and Rosa M R Pereira⁴, ¹Deparment of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Department of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁴Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil
Background/Purpose: Body composition changes resulting from ageing (decreased muscle mass and increased fat tissue) are frequently not accompanied by concomitant changes in body mass index…
Abstract Number: 3071 • 2016 ACR/ARHP Annual Meeting
Recombinant Human Proteoglycan-4 (rhPRG4) Inhibits Monosodium Urate (MSU) Crystal Phagocytosis By Human Macrophages and Resultant Inflammatory Response
Marwa Qadri¹, Tannin Schmidt², Khaled Elsaid³ and Gregory Jay⁴, ¹Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, ²Kinesiology and Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, ³Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, ⁴Emergency Medicine, Brown University, Providence, RI
Background/Purpose: Gout is an inflammatory arthritis caused by precipitation of monosodium urate (MSU) crystals in synovial joints. MSU crystals interact with resident macrophages that…
Abstract Number: 3072 • 2016 ACR/ARHP Annual Meeting
Increased Platelet Reactivity in Gout: Relationship to Tophus Burden and Colchicine Use
Richard Conway¹, Claire-Louise Murphy², Anne Madigan³, Patricia Kavanagh⁴, Liz Geraghty³, Niamh Redmond⁵, Laura Helbert⁶, John J. Carey⁷, Eimear Dunne⁸, Dermot Kenny⁸ and Geraldine M. McCarthy⁹, ¹CARD Newman Research Fellow, University College Dublin, Dublin, Ireland, ²Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ³Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, ⁴Rheumatology Department, Mater Public Hospital, Dublin 7, Ireland, ⁵UCD Clinical Research Centre, Dublin, Ireland, ⁶Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, ⁷Rheumatology, Galway University Hospitals, Galway, Ireland, ⁸Molecular and Cellular Therapeutics, RCSI, Dublin 2, Ireland, ⁹Div of Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland
Background/Purpose: Patients with gout have an increased risk of cardiovascular events. The presence of tophi is associated with enhanced cardiovascular risk. Increased platelet reactivity is…
Abstract Number: 3073 • 2016 ACR/ARHP Annual Meeting
Non-Additive Interaction of the Glucokinase Regulatory Protein and APOBEC1 Complementation Factor Loci with Alcohol Consumption to Influence the Risk of Gout
Humaira Rasheed¹, Lisa K. Stamp², Nicola Dalbeth³ and Tony R. Merriman⁴, ¹University of Engineering and Technology, Lahore, Pakistan, ²University of Otago, Christchurch, New Zealand, ³University of Auckland, Auckland, New Zealand, ⁴Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand
Background/Purpose: Genome-wide association studies (GWAS) have identified loci associated with serum urate levels and the risk of gout. Some of these loci interact in a…
Abstract Number: 3074 • 2016 ACR/ARHP Annual Meeting
Population-Specific Association Between ABCG2 Variants and Tophaceous Disease in People with Gout
Wendy He¹, Amanda Phipps-Green², Lisa K. Stamp³, Tony R. Merriman⁴ and Nicola Dalbeth¹, ¹University of Auckland, Auckland, New Zealand, ²University of Otago, Dunedin, New Zealand, ³University of Otago, Christchurch, New Zealand, ⁴Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand
Background/Purpose: Tophi contribute to musculoskeletal disability, joint damage and poor health-related quality of life in people with gout. The aim of this study was to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].